Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV

Background: In low- and middle-income countries (LMICs), a substantial unmet need for affordable single-tablet regimen (STR) options remains. Rilpivirine (RPV, TMC278) is formulated in a low-cost STR with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC). Objectives: Switching at Low HIV-...

Descrición completa

Detalles Bibliográficos

Principais autores:	Paula Munderi, Edwin Were, Anchalee Avihingsanon, Pascale A.M Mbida, Lerato Mohapi, Samba B. Moussa, Marjolein Jansen, Ceyhun Bicer, Perry Mohammed, Yvon van Delft
Formato:	Artigo
Idioma:	Inglês
Publicado:	AOSIS 2019-07-01
Series:	Southern African Journal of HIV Medicine
Assuntos:	LMIC Single-Tablet-Regimen Virologically suppressed adults Treatment-emergent Resistance SALIF
Acceso en liña:	https://sajhivmed.org.za/index.php/hivmed/article/view/949
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!